To our knowledge, urinary Gal-3 levels in RCC patients have not been investigated, and only one study examined this protein in urine samples from bladder cancer patients, suggesting that it may be a distinguishing feature between bladder cancer patients and control subjects. Here, LGALS3 is linked to urinary bladder cancer.